MedTrace Logo

Diuretics, Hypertension, and Arrhythmias Clinical Trial

NCT00000525 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 233

Last updated 2013-09-19

No results posted yet for this study

Summary

To determine whether hypertensive patients with ECG abnormalities and receiving hydrochlorothiazide diuretics were at increased risk of sudden death.

Conditions

Interventions

DRUG

hydrochlorothiazide

BEHAVIORAL

diet, potassium supplementation

BEHAVIORAL

diet, magnesium supplementation

DRUG

triamterene

DRUG

chlorthalidone

Sponsors & Collaborators

Principal Investigators

  • Stephen Hulley · University of California

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1986-07-31
Primary Completion
1989-09-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000525 on ClinicalTrials.gov